Sign in

Kaplan Ling

Research Analyst at Essence Securities

Kaplan Ling is a Research Analyst at Essence Securities with a focus on equity research, actively participating in earnings calls and covering companies such as Akso Health. While Ling's public track record details are limited, available data indicate direct engagement with company management through question participation in financial results briefings. Ling's tenure and previous industry experience prior to joining Essence Securities are not extensively documented, suggesting a recent entry or a discreet research role within the firm. Specific professional credentials, securities licenses, or industry certifications for Ling are not publicly listed at this time.

Kaplan Ling's questions to Akso Health (AHG) leadership

Question · Q3 2019

Kaplan Ling from Essence Securities requested the company's outlook for the upcoming fiscal year concerning loan volume, borrower, and lender growth. He also asked about Hexindai's mergers and acquisitions strategy and its primary areas of focus.

Answer

CEO Xinming Zhou stated that guidance for the next fiscal year would be issued on the following earnings call. Regarding M&A, Mr. Zhou confirmed the company will continue to seek investment opportunities in the online lending business, highlighting its recent investments in an Indonesian platform and Phoenix Intelligent Credit, with a strategic focus on emerging markets like Southeast Asia.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts